Cargando…
Experimental Serotonergic Agents for the Treatment of Schizophrenia
Schizophrenia remains one of the most chronic and highly disabling mental disorder. To date, the pathomechanism of schizophrenia is not fully understood and current treatments are characterized by some limitations. First- and second-generation antipsychotics have shown clinical efficacy in treating...
Autores principales: | Capuzzi, Enrico, Caldiroli, Alice, Ciscato, Veronica, Russo, Stefania, Buoli, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872893/ https://www.ncbi.nlm.nih.gov/pubmed/33574716 http://dx.doi.org/10.2147/JEP.S259317 |
Ejemplares similares
-
Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2022) -
Sociodemographic and clinical characteristics associated with delirium in hospitalized patients with COVID-19: are immigrants a vulnerable group?
por: Capuzzi, Enrico, et al.
Publicado: (2023) -
Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021) -
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021) -
Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
por: Buoli, Massimiliano, et al.
Publicado: (2012)